World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
38241
World Ranking
9572
National Ranking
525

Overview

Ralf Gold is affiliated with Ruhr University Bochum in Germany and has made substantial contributions to the field of medicine, focusing prominently on neurology and immunology. Their research agenda encompasses multiple sclerosis and related neurological disorders, with a broad engagement in pathology, forensic medicine, oncology, and molecular biology.

The main topics of their work include:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Hereditary Neurological Disorders
  • Polyomavirus and related diseases
  • Peripheral Nerve Disorders
  • Parkinson's Disease Mechanisms and Treatments
  • Myasthenia Gravis and Thymoma

They have published extensively in key journals, with frequent publication venues consisting of:

  • Neurology
  • Therapeutic Advances in Neurological Disorders
  • Journal of Neurology
  • Neurology Neuroimmunology & Neuroinflammation
  • Multiple Sclerosis Journal

Ralf Gold's recent publications highlight their focus on immunomodulation and neurological disease management. Notable papers include:

  • "Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism," 2020, Cell
  • "Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism," 2021, European Heart Journal
  • "Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)," 2021, Therapeutic Advances in Neurological Disorders
  • "Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management," 2023, Journal of Neurology
  • "Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders," 2021, Neurology Neuroimmunology & Neuroinflammation

The researcher has collaborated frequently with a group of co-authors including Jeremias Motte, Kalliopi Pitarokoili, Anna Lena Fisse, Simon Faissner, and Thomas Grüter.

Best Publications

  • Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

    Ralf Gold;Ludwig Kappos;Douglas L Arnold;Amit Bar-Or

  • Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution.

    Takahiro Masuda;Roman Sankowski;Ori Staszewski;Chotima Böttcher

  • Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

    Ralf A Linker;De-Hyung Lee;Sarah Ryan;Anne M van Dam

  • ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

    X. Montalban;R. Gold;A. J. Thompson;S. Otero‐Romero

  • Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine

    Aiden Haghikia;Stefanie Jörg;Alexander Duscha;Johannes Berg

  • Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

    Ludwig Kappos;Ralf Gold;David H Miller;David G MacManus

  • Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism

    Alexander Duscha;Barbara Gisevius;Sarah Hirschberg;Nissan Yissachar

  • Sex and gender issues in multiple sclerosis

    Hanne F. Harbo;Ralf Gold;Mar Tintoré

  • TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

    Adam P. Gregory;Calliope A. Dendrou;Kathrine E. Attfield;Aiden Haghikia;Aiden Haghikia

  • Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

    Ludwig Kappos;David Bates;Gilles Edan;Mefkûre Eraksoy

  • Tumor Recurrence and Survival in Patients Treated for Thymomas and Thymic Squamous Cell Carcinomas: A Retrospective Analysis

    Philipp Ströbel;Andrea Bauer;Bernhard Puppe;Til Kraushaar

  • Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis

    Rajneesh Srivastava;Muhammad Aslam;Sudhakar Reddy Kalluri;Lucas Schirmer

  • Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

    G Giancarlo Comi;A. Pulizzi;Marco Rovaris;O. Abramsky

  • Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

    Alexander Baraniskin;Jan Kuhnhenn;Uwe Schlegel;Andrew Chan

  • Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.

    Simon Faissner;Simon Faissner;Jason R Plemel;Ralf Gold;V Wee Yong

  • Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

    Ralf Gold;Gavin Giovannoni;Krzysztof Selmaj;Eva Havrdova

  • Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.

    Nico Melzer;Tobias Ruck;Peter Fuhr;Ralf Gold

  • Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab.

    Per Soelberg Sørensen;Antonio Bertolotto;Gilles Edan;Gavin Giovannoni

  • Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder.

    Marius Ringelstein;Ilya Ayzenberg;Jens Harmel;Ann-Sophie Lauenstein

  • Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy

    Ilya Ayzenberg;Ingo Kleiter;Alexandra Schröder;Kerstin Hellwig

Frequent Co-Authors

Andrew T. Chan
Andrew T. Chan Harvard University
Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Heinz Wiendl
Heinz Wiendl University of Münster
Frauke Zipp
Frauke Zipp Johannes Gutenberg University of Mainz
Amit Bar-Or
Amit Bar-Or University of Pennsylvania
Eva Havrdova
Eva Havrdova Charles University
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Krzysztof Selmaj
Krzysztof Selmaj University of Warmia and Mazury in Olsztyn
Friedemann Paul
Friedemann Paul Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees and career pathways can open doors to diverse roles in medicine, patient care, and public health. For those looking to bypass lengthy prerequisites, consider nursing schools that don't require teas, offering a streamlined entry to nursing careers without standardized test hurdles.

Leadership roles in healthcare are in high demand. Completing one of the top healthcare administration programs can prepare you for management positions in hospitals, clinics, or health organizations—all through fast-track online options.

If you’re already an RN aiming to advance, adn to fnp bridge programs provide a flexible route to become a Family Nurse Practitioner, expanding your scope of practice and responsibility.

For those interested in preventive care and wellness, an accredited nutrition degrees online can prepare you for rewarding roles in dietary planning, research, or public health education. These pathways support a future in medicine or related healthcare fields with flexible, accredited online study.

Best Scientists Citing Ralf Gold

Trending Scientists

Recently Published Articles